# US 2019/0170755 A1 · Detection Method of Circulating Tumor Cells and Pretreatment Method for Detecting Circulating Tumor Cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0170755 A1
- Document ID: US20190170755A1
- Status: Published application
- Kind: A1
- Application number: 16/324,373
- Filed: 2017-08-14
- Published: 2019-06-06
- Earliest claimed: 2016-08-12
- Assignees: Hitachi Chemical Company, Ltd.
- Applicants: Hitachi Chemical Company, Ltd.
- Inventors: Katsuya Endou; Seita Nakamura; Tatsuya Matsunaga; Satomi Yagi; Masayuki Higuchi; Anthony H. Tsai
- Web page: https://patentgrep.com/patent/US20190170755A1

## CPC

- G01N 33/57585: {involving compounds identifiable in body fluids}
- C12Q 1/04: Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor {(C12Q1/6897 takes precedence)}
- C12Q 1/6825: Nucleic acid detection involving sensors
- G01N 33/48: Biological material, e.g. blood, urine (G01N33/02, G01N33/26, G01N33/44, G01N33/46 take precedence); Haemocytometers (counting blood corpuscules distributed over a surface by scanning the surface G06M11/02)
- G01N 33/53: Immunoassay; Biospecific binding assay; Materials therefor
- G01N 33/575: for cancer
- G01N 33/582: {with fluorescent label}
- G01N 33/6857: {Antibody fragments}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The present invention provides a method for detecting circulating tumor cells, comprising steps of: capturing cells in a blood sample on a filter; contacting an antibody that is labeled with a first fluorescent dye and recognizes a leukocyte marker protein with the cell-captured filter; contacting an animal serum, a surfactant and an antibody that is labeled with a second fluorescent dye and recognizes an epithelial cell marker protein with the cell-captured filter; contacting a third fluorescent dye that stains nucleic acids with the cell-captured filter; and detecting fluorescences emitted from each cell captured on the filter.

## Claims

### Claim 1

A method for detecting circulating tumor cells in a blood sample, comprising steps of:
(a) filtering a blood sample through a filter to capture cells on the filter;
(b) contacting with the cell-captured filter,
a primary antibody that recognizes a leukocyte marker protein, and subsequently a secondary antibody that recognizes the primary antibody and is labeled with a first fluorescent dye, or
an antibody that recognizes a leukocyte marker protein and is labeled with a first fluorescent dye;
(c) contacting
(c1) an animal serum,
(c2) a surfactant and
(c3) an antibody that recognizes an epithelial cell marker protein and is labeled with a second fluorescent dye
with the cell-captured filter simultaneously or in any order;
(d) contacting a third fluorescent dye that stains nucleic acids with the cell-captured filter; and
(e) irradiating the cell-captured filter with respective excitation lights of the first, second and third fluorescent dyes to detect respective fluorescences of the first, second and third fluorescent dyes emitted from each cell captured on the filter,
wherein step (d) is performed at any stage between step (a) and step (e).

### Claim 2

(canceled)

### Claim 3 (depends on 1)

The method according to claim 1, wherein step (c) and step (d) are performed simultaneously to contact (c1), (c2), (c3) and the third fluorescent dye that stains nucleic acids simultaneously with the cell-captured filter.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the surfactant comprises a nonionic surfactant.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the surfactant comprises polyoxyethylene octyl phenyl ether.

### Claim 6 (depends on 1)

The method according to claim 1, wherein a concentration of the surfactant is 0.05% by mass to 0.2% by mass.

### Claim 7 (depends on 1)

The method according to claim 1, wherein an animal from which the animal serum derives, an animal from which the primary antibody or the antibody that recognizes a leukocyte marker protein derives, and an animal from which the antibody that recognizes an epithelial cell marker protein derives are the same animal.

### Claim 8 (depends on 7)

The method according to claim 7, wherein the animal is a mouse.

### Claim 9 (depends on 1)

The method according to claim 1, wherein a concentration of the animal serum is 2% by mass to 10% by mass.

### Claim 10 (depends on 1)

The method according to claim 1, wherein the leukocyte marker protein is CD45.

### Claim 11 (depends on 1)

The method according to claim 1, wherein the epithelial cell marker protein is cytokeratin or a tumor marker.

### Claim 12

A pretreatment method for detecting circulating tumor cells on a cell-captured filter, comprising a step of contacting an animal serum and a surfactant with the cell-captured filter simultaneously or in any order.

### Claim 13 (depends on 12)

The method according to claim 12, wherein the cell-captured filter is treated with
a primary antibody that recognizes a leukocyte marker protein and a secondary antibody that recognizes the primary antibody and is labeled with a first fluorescent dye, or
an antibody that recognizes a leukocyte marker protein and is labeled with a first fluorescent dye
prior to the step of contacting the animal serum and the surfactant.

### Claim 14

(canceled)

### Claim 15 (depends on 13)

The method according to claim 13, wherein the animal serum, the surfactant, an antibody that recognizes an epithelial cell marker protein and is labeled with a second fluorescent dye, and a third fluorescent dye that stains nucleic acids are simultaneously contacted with the cell-captured filter.

### Claim 16 (depends on 12)

The method according to claim 12, wherein the surfactant comprises a nonionic surfactant.

### Claim 17 (depends on 12)

The method according to claim 12, wherein the surfactant comprises polyoxyethylene octyl phenyl ether.

### Claim 18 (depends on 12)

The method according to claim 12, wherein a concentration of the surfactant is 0.05% by mass to 0.2% by mass.

### Claim 19 (depends on 15)

The method according to claim 15, wherein an animal from which the animal serum derives, an animal from which the primary antibody or the antibody that recognizes a leukocyte marker protein derives, and an animal from which the antibody that recognizes an epithelial cell marker protein derives are the same animal.

### Claim 20 (depends on 19)

The method according to claim 19, wherein the animal is a mouse.

### Claim 21 (depends on 12)

The method according to claim 12, wherein a concentration of the animal serum is 2% by mass to 10% by mass.

### Claim 22 (depends on 13)

The method according to claim 13, wherein the leukocyte marker protein is CD45.

### Claim 23 (depends on 15)

The method according to claim 15, wherein the epithelial cell marker protein is cytokeratin or a tumor marker.
